SCI时时刷

search
+
An absence of translated consent forms limits oncologic clinical trial enrollment for limited English proficiency participants
An absence of translated consent forms limits oncologic clinical trial enrollment for limited English proficiency participants
Volume 180, January 2024, Pages 86-90Author links open overlay panel, , , , AbstractObjectivesA lack of diversity amongst ...
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
KeywordsHomologous-recombination-deficiency (HRD)High-grade serous ovarian cancer (HGSC)Whole-genome-sequencing (WGS)Genet...
Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts
Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts
Approximately one in four cervical cancer patients suffers from recurrence following primary treatment [1]. Even patients ...
Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US
Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US
Worldwide, cervical cancer is the fourth most commonly diagnosed cancer and the fourth leading cause of cancer-related dea...
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma
N. Colombo et al.ESMO–ESGO–ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-upRadiother. ...
Health care services utilization in patients with ovarian cancer receiving PARP inhibitor maintenance treatment in a US community oncology setting
Health care services utilization in patients with ovarian cancer receiving PARP inhibitor maintenance treatment in a US community oncology setting
Ovarian cancer accounts for 1.0% of all cancers and is the fifth leading cause of cancer-related death in women [1]. It is...
Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer
Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer
Management of menopausal symptoms in patients with uterine cancer remains clinically challenging [1,2]. As uterine cancer ...
Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement
Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement
The most locally advanced International Federation of Gynecology and Obstetrics (FIGO) stage of cervical cancer is IVA dis...
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
Ovarian cancer (OC), specifically high-grade serous ovarian cancer (HGSOC), is characterized by deficiencies in homologous...
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
Human epidermal growth factor receptor 2 (HER2) is tyrosine kinase receptor encoded by the ERBB2 gene [1]. ERBB2 amplifica...
Image-guided high-dose-rate brachytherapy as the method of choice in medically inoperable early-stage endometrial cancer patients
Image-guided high-dose-rate brachytherapy as the method of choice in medically inoperable early-stage endometrial cancer patients
With 130,051 new cases and 29,963 deaths in 2020 endometrial carcinoma remains the most common gynaecological malignancy i...
Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications
Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications
Ovarian cancer remains the most deadly gynecologic cancer, with less than half of patients living more than five years aft...
Factors associated with failed ‘test of cure’ in the NHS Cervical Screening Programme: A retrospective cohort study
Factors associated with failed ‘test of cure’ in the NHS Cervical Screening Programme: A retrospective cohort study
ObjectiveTo determine predictive factors associated with failed ‘test of cure’ (TOC) in the NHS Cervical Screening Program...
Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to cervical cancer questions
Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to cervical cancer questions
Artificial Intelligence (AI) is a rapidly evolving field with significant applications across many professions, including ...
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
In 2023, an estimated 19,710 women will be diagnosed with ovarian cancer and 13,270 patients will die from this disease in...
Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation
Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation
Endometrial cancer is the most common gynecologic malignancy in the United States. In 2023, an estimated 66,200 women will...
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer – An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer – An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
The trial protocol is available on the study website. The individual participant data that underlie the results reported i...
Integrating social care into gynecologic oncology: Identifying and addressing patient's social needs
Integrating social care into gynecologic oncology: Identifying and addressing patient's social needs
Cancer risk and health outcomes are affected by various factors, including biological/genetic predisposition, behavioral f...
Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement
Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement
Epithelial ovarian cancer (EOC) is detected at an early stage in up to 20% of patients, requiring complete staging surgery...
Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus
Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus
Endometrial cancer is the most common gynecologic cancer in the US, and most patients are diagnosed with early-stage disea...
Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement
Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement
Cervical cancer is the most commonly diagnosed gynecologic cancer worldwide. Although the incidence has declined with incr...
Impact of limiting reproductive rights of pregnant individuals with cancer in the United States
Impact of limiting reproductive rights of pregnant individuals with cancer in the United States
Available online 18 November 2023Author links open overlay panel, , , , , , , Section snippetsAuthor contributionsThis wor...
Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis
Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis
ObjectiveThe addition of immune checkpoint inhibitors (ICIs), pembrolizumab or dostarlimab, to paclitaxel and carboplatin ...
Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery.
Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery.
Volume 179, December 2023, Pages 42-51Author links open overlay panel, , , , , , , , , , , , , , Highlights•Oncovascular s...
Survival differences by race and surgical approach in early-stage operable cervical Cancer
Survival differences by race and surgical approach in early-stage operable cervical Cancer
Due to effective screening and dysplasia treatment, death from cervical cancer has dramatically decreased in American pati...
Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review
Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review
Early-stage cervical cancer is commonly treated with surgery while locally advanced disease is treated with definitive con...
Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis
Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis
Ovarian cancer is a leading cause of death from gynecological malignancies, with an estimated 313,959 new cases and 207,25...
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
ObjectiveTo explore possible associations between modifiable lifestyle factors and health-related quality of life (HRQoL) ...
Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers
Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers
Since 2000, the incidence of cervical cancer in the United States has declined due to screening and preventive HPV vaccina...
Aberrant nuclear β-catenin distribution does not prognosticate recurrences of endometrioid endometrial cancers – A retrospective single-institutional study
Aberrant nuclear β-catenin distribution does not prognosticate recurrences of endometrioid endometrial cancers – A retrospective single-institutional study
Endometrial cancer is the most common gynecologic malignancy in developed countries with a slow but constant rise in both ...
阅读更多
format_indent_increase